First report of teclistamab in a patient with relapsed AL amyloidosis and multiple myeloma
eJHaem · 2023-11 · 4 (4) · 1157-1159
DOI: 10.1002/jha2.772 ↗Kurz gefasst
Fallbericht in der Zeitschrift eJHaem, online erschienen am 21.08.2023. Verfasst von Nelson Leung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension Mayo Clinic Rochester Minnesota USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension Mayo Clinic Rochester Minnesota USA.
- Division of Hematology Mayo Clinic Rochester Minnesota USA.
- Community Health Network MD Anderson Indianapolis Indiana USA.
ORCID-Profile: Nelson Leung
Zitieren
APA
Leung, N., Chapman, J. A., & Bhatia, S. (2023). First report of teclistamab in a patient with relapsed AL amyloidosis and multiple myeloma. eJHaem, 4(4), 1157-1159. https://doi.org/10.1002/jha2.772
Vancouver
Leung N, Chapman JA, Bhatia S. First report of teclistamab in a patient with relapsed AL amyloidosis and multiple myeloma. eJHaem. 2023;4(4):1157-1159. doi:10.1002/jha2.772
BibTeX
@article{Leung2023,
author = {Leung, Nelson and Chapman, Jennifer A and Bhatia, Sumeet},
title = {First report of teclistamab in a patient with relapsed AL amyloidosis and multiple myeloma},
journal = {eJHaem},
year = {2023},
volume = {4},
number = {4},
pages = {1157--1159},
doi = {10.1002/jha2.772}
}
EUVIMED